cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA385694 | thyroid gland | .d | 1346 to 1569 | 1 to 224 | 224/224 (100 %) | 1 diff (99.6 %id) | |||
AK301787 | testis | .a | 1 to 1293 | 1 to 1293 | Q91R | tiling clone, | 1293/1293 (100 %) | 1 diff (100.0 %id) | |
AK310561 | thymus | .b | 4 to 1427 | 1 to 1424 | exact | tiling clone, | 1424/1424 (100 %) | 0 diff (100 %id) | |
AY358448 | .a | 35 to 1351 | 1 to 1317 | exact | 1317/1319 (99 %) | 1 diff (100.0 %id) | |||
CB155551 | brain | .b | 171 to 346 | 1 to 176 | 176/176 (100 %) | 6 diff (96.6 %id) | |||
BC057833 | Placenta, normal | .a | 206 to 1355 | 1 to 1150 | exact | tiling clone, available from MGC, AAA | 1150/1150 (100 %) | 0 diff (100 %id) | |
BM311187 | Pancreas, Purified pancreatic islet | .a | 1278 to 1769 | 11 to 502 | 492/502 (98 %) | 6 diff (98.9 %id) | |||
BM311774 | Pancreas, Purified pancreatic islet | .a | 1459 to 1934 | 476 to 1 | 476/476 (100 %) | 1 diff (99.8 %id) | |||
BM504137 | insulinoma, Pancreas | .a | 1483 to 1934 | 465 to 14 | AAA | 452/458 (98 %) | 1 diff (99.8 %id) | ||
BM504361 | insulinoma, Pancreas | .a | 1483 to 1916 | 8 to 441 | 434/441 (98 %) | 1 diff (99.8 %id) | |||
CN265472 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1711 to 2207 | 1 to 499 | tiling clone, | 499/499 (100 %) | 6 diff (98.8 %id) | ||
CR616301 | Placenta Cot 25-normalized | .d | 1 to 1615 | 1 to 1615 | exact | tiling clone, | 1615/1615 (100 %) | 0 diff (100 %id) | |
CR623920 | neuroblastoma | .a | 195 to 1325 | 1 to 1131 | exact | 1131/1131 (100 %) | 0 diff (100 %id) | ||
CR746690 | insulinoma, Pancreas | .a | 1483 to 1903 | 108 to 528 | 421/528 (79 %) | 6 diff (98.9 %id) | |||
AL518937 | brain, neuroblastoma, neuroblastoma cells | .a | 777 to 1319 | 550 to 7 | 544/1111 (48 %) | 0 diff (100 %id) | |||
AL518938 | brain, neuroblastoma, neuroblastoma cells | .a | 195 to 801 | 1 to 606 | 606/1009 (60 %) | 23 diff (97.8 %id) | |||
BX374349 | Neuroblastoma Cot 10-normalized | .a | 210 to 1071 | 28 to 883 | 856/883 (96 %) | 17 diff (98.1 %id) | |||
AL525821 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .d | 692 to 1552 | 870 to 8 | 863/870 (99 %) | 7 diff (99.2 %id) | |||
AL525865 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .b | 208 to 794 | 1 to 586 | 586/586 (100 %) | 7 diff (98.9 %id) | |||
BX387117 | Neuroblastoma Cot 25-normalized | .d | 6 to 785 | 1 to 780 | 780/780 (100 %) | 7 diff (99.2 %id) | |||
BX357560 | Placenta Cot 25-normalized | .d | 755 to 1615 | 857 to 1 | fully sequenced, | 857/857 (100 %) | 8 diff (99.1 %id) | ||
BX357561 | Placenta Cot 25-normalized | .d | 1 to 816 | 1 to 814 | A27X A28P S29L R30V A31L ... | fully sequenced, | 814/814 (100 %) | 5 diff (99.4 %id) | |
EC539150 | Prostate | .a | 1039 to 1136 | 1 to 97 | 97/99 (97 %) | 9 diff (91.0 %id) | |||
EL734103 | mixed | .a | 232 to 890 | 1 to 659 | 659/659 (100 %) | 2 diff (99.7 %id) | |||
EL946534 | eyeball | .b | 218 to 782 | 1 to 564 | 564/564 (100 %) | 4 diff (99.3 %id) | |||
DB567988 | hypothalamus | .a | 886 to 1353 | 1 to 468 | Submitted on the opposite strand | 468/470 (99 %) | 5 diff (99.0 %id) | ||
N92192 | multiple sclerosis lesions | .d | 908 to 1466 | 1 to 544 | 544/606 (89 %) | 17 diff (97.2 %id) | |||
AA496419 | ovarian tumor, ovary | .a | 1498 to 1926 | 1 to 430 | 430/430 (100 %) | 2 diff (99.6 %id) | |||
AA456566 | ovarian tumor, ovary | .a | 1565 to 1937 | 376 to 4 | 373/376 (99 %) | 0 diff (100 %id) | |||
AA548389 | germ cell tumor | .a | 919 to 1356 | 436 to 1 | 436/436 (100 %) | 5 diff (98.9 %id) | |||
AA649964 | normal prostate, Prostate | .a | 922 to 1356 | 435 to 3 | 433/435 (99 %) | 0 diff (100 %id) | |||
AI142829 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1008 to 1351 | 350 to 7 | 344/351 (98 %) | 0 diff (100 %id) | |||
AI380679 | B-cell, chronic lymphotic leukemia | .a | 972 to 1351 | 388 to 10 | 379/388 (97 %) | 0 diff (100 %id) | |||
AI471526 | colon, moderately-differentiated adenocarcinoma | .a | 887 to 1351 | 466 to 2 | 465/466 (99 %) | 0 diff (100 %id) | |||
AI624274 | adenocarcinoma, Pancreas | .a | 898 to 1355 | 470 to 13 | AAA | 458/458 (100 %) | 0 diff (100 %id) | ||
AI805053 | Prostate | .a | 936 to 1355 | 420 to 1 | 420/420 (100 %) | 0 diff (100 %id) | |||
AI819168 | lymph node, lymphoma, follicular mixed small and largecell | .d | 1225 to 1626 | 403 to 1 | tiling clone, | 403/403 (100 %) | 19 diff (95.3 %id) | ||
AI889549 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 965 to 1359 | 414 to 20 | AAA | 395/395 (100 %) | 3 diff (99.3 %id) | ||
AI937663 | anaplastic oligodendroglioma, brain | .a | 1016 to 1354 | 342 to 2 | 341/342 (99 %) | 0 diff (100 %id) | |||
AW006720 | Prostate | .a | 898 to 1351 | 454 to 1 | 454/454 (100 %) | 0 diff (100 %id) | |||
AW006482 | colon | .a | 1055 to 1355 | 325 to 25 | AAA | 301/301 (100 %) | 7 diff (97.7 %id) | ||
AI968598 | pooled germ cell tumors | .a | 1038 to 1355 | 349 to 32 | AAA | 318/318 (100 %) | 7 diff (97.8 %id) | ||
AW072426 | pooled | .a | 898 to 1361 | 468 to 5 | 464/468 (99 %) | 0 diff (100 %id) | |||
AW013989 | .a | 965 to 1355 | 408 to 18 | AAA | 391/391 (100 %) | 1 diff (99.8 %id) | |||
AW451181 | .a | 1543 to 1934 | 409 to 18 | AAA | 392/405 (96 %) | 0 diff (100 %id) | |||
BE298018 | muscle, rhabdomyosarcoma | .a | 219 to 940 | 1 to 715 | 715/749 (95 %) | 21 diff (97.2 %id) | |||
BE645645 | Prostate | .a | 1092 to 1355 | 279 to 16 | AAA | 264/264 (100 %) | 1 diff (99.7 %id) | ||
BF475729 | sciatic nerve | .a | 1050 to 1351 | 308 to 7 | 302/308 (98 %) | 0 diff (100 %id) | |||
BE295825 | muscle, rhabdomyosarcoma | .a | 218 to 876 | 1 to 656 | 656/662 (99 %) | 16 diff (97.6 %id) | |||
BC005015 | Placenta, choriocarcinoma | .a | 621 to 1934 | 1 to 1314 | tiling clone, available from MGC, AAA | 1314/1314 (100 %) | 0 diff (100 %id) | ||
BE904570 | epithelioid carcinoma, Pancreas | .b | 215 to 338 | 1 to 124 | 124/124 (100 %) | 0 diff (100 %id) | |||
BE910102 | epithelioid carcinoma, Pancreas | .d | 29 to 136 | 1 to 108 | 108/108 (100 %) | 0 diff (100 %id) | |||
BE958622 | brain, primitive neuroectoderm | .b | 208 to 755 | 1 to 547 | 547/675 (81 %) | 33 diff (95.2 %id) | |||
BE796333 | lung, small cell carcinoma | .a | 1007 to 1366 | 1 to 359 | AAA | 359/359 (100 %) | 1 diff (99.8 %id) | ||
BE741022 | adenocarcinoma cell line, ovary | .a | 861 to 1350 | 1 to 491 | 491/491 (100 %) | 6 diff (98.8 %id) | |||
BF347570 | anaplastic oligodendroglioma with 1p/19qloss, brain | .b | 216 to 358 | 12 to 156 | 145/156 (92 %) | 6 diff (96.2 %id) | |||
BF663486 | B-cells, primary B-cells from tonsils (cell line) | .a | 211 to 1009 | 1 to 794 | 794/911 (87 %) | 26 diff (97.2 %id) | |||
BF664523 | B-cells, primary B-cells from tonsils (cell line) | .a | 211 to 945 | 1 to 726 | 726/925 (78 %) | 15 diff (98.4 %id) | |||
BG113193 | Bone, osteosarcoma, cell line | .d | 68 to 156 | 1 to 89 | 89/89 (100 %) | 0 diff (100 %id) | |||
BG023868 | duodenal adenocarcinoma, cell line, small intestine | .b | 210 to 358 | 8 to 156 | 149/156 (95 %) | 6 diff (96.2 %id) | |||
BG704382 | brain, hippocampus | .a | 160 to 847 | 1 to 687 | 687/687 (100 %) | 22 diff (96.8 %id) | |||
BG762728 | melanotic melanoma, high MDR (cell line), skin | .a | 209 to 942 | 1 to 734 | 734/734 (100 %) | 2 diff (99.8 %id) | |||
BG913677 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 2016 to 2514 | 12 to 528 | tiling clone, | 517/1077 (48 %) | 30 diff (97.3 %id) | ||
BI819000 | pooled brain, lung, testis | .d | 16 to 158 | 1 to 144 | 144/144 (100 %) | 1 diff (99.4 %id) | |||
BI755330 | brain | .a | 714 to 1279 | 1 to 565 | 565/565 (100 %) | 1 diff (99.9 %id) | |||
BI767877 | pooled lung and spleen | .a | 258 to 1132 | 1 to 883 | 883/886 (99 %) | 54 diff (94.0 %id) | |||
BI910286 | leukocyte | .a | 211 to 880 | 1 to 675 | 675/675 (100 %) | 21 diff (96.9 %id) | |||
BI916652 | brain | .b | 201 to 360 | 1 to 160 | 160/160 (100 %) | 0 diff (100 %id) | |||
BI600340 | brain, hypothalamus | .a | 182 to 888 | 1 to 707 | 707/707 (100 %) | 7 diff (99.1 %id) | |||
BM894080 | insulinoma, Pancreas | .a | 1483 to 1934 | 468 to 17 | AAA | 452/458 (98 %) | 1 diff (99.8 %id) | ||
BM894353 | insulinoma, Pancreas | .a | 1483 to 1934 | 8 to 459 | AAA | 452/459 (98 %) | 1 diff (99.8 %id) | ||
CK905601 | insulinoma, Pancreas | .a | 1483 to 1934 | 469 to 18 | AAA | 452/458 (98 %) | 1 diff (99.8 %id) | ||
BM544798 | brain, hippocampus | .a | 220 to 1070 | 16 to 869 | 854/1097 (77 %) | 23 diff (98.0 %id) | |||
BM921810 | pooled brain, lung, testis | .b | 182 to 773 | 12 to 605 | 594/632 (93 %) | 35 diff (94.5 %id) | |||
BM923817 | pooled colon, kidney, stomach | .a | 203 to 1041 | 1 to 842 | 842/981 (85 %) | 12 diff (98.8 %id) | |||
BQ064953 | lymph, lymphoma, cell line | .a | 641 to 1354 | 720 to 1 | Submitted on the opposite strand | 720/1102 (65 %) | 20 diff (98.2 %id) | ||
BQ222156 | epithelioid carcinoma, Pancreas | .c | 1 to 841 | 1 to 856 | V229S S231L P233A A234S L235T ... | tiling clone, | 856/883 (96 %) | 19 diff (97.9 %id) | |
BQ676029 | melanotic melanoma, cell line, skin | .a | 248 to 1166 | 1 to 928 | 928/931 (99 %) | 36 diff (96.2 %id) | |||
BQ677123 | melanotic melanoma, cell line, skin | .a | 245 to 1051 | 21 to 832 | 812/927 (87 %) | 22 diff (97.7 %id) | |||
BQ898375 | lymph, lymphoma, cell line | .a | 566 to 1349 | 794 to 6 | Submitted on the opposite strand | 789/918 (85 %) | 12 diff (98.7 %id) | ||
BQ942912 | large cell carcinoma, lung | .b | 212 to 733 | 1 to 526 | 526/771 (68 %) | 13 diff (98.4 %id) | |||
CA487554 | .b | 215 to 716 | 1 to 503 | 503/1073 (46 %) | 29 diff (97.3 %id) | ||||
CA454574 | .a | 224 to 916 | 1 to 693 | 693/854 (81 %) | 17 diff (98.1 %id) | ||||
CA454722 | .b | 197 to 589 | 1 to 393 | 393/982 (40 %) | 5 diff (99.5 %id) | ||||
CA454881 | .a | 270 to 994 | 1 to 728 | 728/937 (77 %) | 12 diff (98.8 %id) | ||||
CB960578 | Human Placenta, placenta | .a | 197 to 948 | 19 to 770 | 752/771 (97 %) | 8 diff (99.0 %id) | |||
CB959592 | Human Placenta, placenta | .a | 626 to 1249 | 27 to 654 | 628/822 (76 %) | 18 diff (97.9 %id) | |||
CD518858 | White Matter | .a | 187 to 969 | 1 to 785 | 785/873 (89 %) | 9 diff (99.0 %id) | |||
TI_57217081 | .a | 713 to 1279 | 35 to 600 | 566/600 (94 %) | 6 diff (99.0 %id) | ||||
TI_57196473 | .a | 214 to 1055 | 34 to 880 | 847/880 (96 %) | 14 diff (98.5 %id) | ||||
TI_57183967 | .a | 255 to 1132 | 61 to 946 | 886/949 (93 %) | 54 diff (94.4 %id) | ||||
TI_57236161 | .a | 205 to 880 | 29 to 709 | 681/709 (96 %) | 19 diff (97.4 %id) | ||||
TI_57240127 | .a | 193 to 996 | 30 to 833 | 804/833 (96 %) | 6 diff (99.3 %id) | ||||
TI_45215331 | .a | 187 to 888 | 131 to 832 | 702/832 (84 %) | 8 diff (99.1 %id) | ||||
DC362461 | Kidney | .b | 1 to 579 | 1 to 578 | 578/578 (100 %) | 1 diff (99.9 %id) | |||
CB120711 | Liver | .b | 197 to 717 | 1 to 521 | 521/521 (100 %) | 2 diff (99.7 %id) | |||
CB145111 | Liver | .d | 35 to 268 | 1 to 234 | 234/234 (100 %) | 3 diff (98.8 %id) | |||
NM_207340.1 | .a | 35 to 1353 | 1 to 1319 | exact | RefSeq, | 1319/1319 (100 %) | 2 diff (99.9 %id) | ||
DA704564 | .a | 52 to 542 | 2 to 491 | capped | 490/490 (100 %) | 1 diff (99.8 %id) | |||
DB323912 | .a | 1397 to 1934 | 539 to 1 | 539/539 (100 %) | 2 diff (99.7 %id) | ||||
CR990053 | T-Lymphocytes | .d | 8 to 602 | 1 to 595 | 595/598 (99 %) | 1 diff (99.9 %id) | |||
BM831506 | stomach | .b | 200 to 719 | 1 to 520 | 520/520 (100 %) | 1 diff (99.9 %id) | |||
BM791179 | stomach | .b | 200 to 794 | 1 to 595 | 595/595 (100 %) | 1 diff (99.9 %id) | |||
BM791695 | stomach | .b | 205 to 754 | 1 to 550 | 550/550 (100 %) | 0 diff (100 %id) | |||
BM795394 | stomach | .b | 200 to 407 | 1 to 209 | 209/209 (100 %) | 2 diff (99.1 %id) | |||
BM854545 | stomach | .b | 200 to 584 | 1 to 385 | 385/385 (100 %) | 1 diff (99.8 %id) | |||
BM797238 | Ascites, stomach | .a | 1083 to 1516 | 1 to 434 | 434/434 (100 %) | 4 diff (99.1 %id) | |||
TI_1948208667 | .a | 231 to 668 | 132 to 572 | fully sequenced, | 441/572 (77 %) | 6 diff (99.0 %id) | |||
TI_1948208668 | .a | 638 to 1085 | 581 to 124 | fully sequenced, | 458/581 (78 %) | 8 diff (98.7 %id) | |||
TI_1948209005 | .a | 231 to 791 | 124 to 684 | fully sequenced, | 561/684 (82 %) | 7 diff (99.0 %id) | |||
TI_1948209006 | .a | 760 to 1085 | 452 to 126 | fully sequenced, | 327/452 (72 %) | 1 diff (99.8 %id) | |||
DR007011 | Spleen | .d | 18 to 685 | 8 to 675 | 668/675 (98 %) | 7 diff (99.0 %id) | |||
DC395291 | testis | .b | 5 to 554 | 1 to 550 | 550/551 (99 %) | 2 diff (99.7 %id) | |||
DB094607 | testis | .b | 226 to 786 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
DC405233 | thymus | .b | 4 to 581 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
DC406006 | thymus | .b | 1 to 566 | 1 to 566 | tiling clone, | 566/566 (100 %) | 0 diff (100 %id) | ||
TI_154034516 | .d | 997 to 1625 | 697 to 82 | AAA | 616/771 (79 %) | 19 diff (97.6 %id) | |||
BM664925 | eye, optic nerve | .a | 1063 to 1355 | 311 to 19 | fully sequenced, AAA | 293/293 (100 %) | 0 diff (100 %id) | ||
BM702244 | eye, optic nerve | .a | 891 to 1355 | 1 to 465 | fully sequenced, AAA | 465/465 (100 %) | 0 diff (100 %id) | ||
CA443600 | lung, Metastatic Chondrosarcoma | .d | 1175 to 1625 | 469 to 19 | AAA | 451/451 (100 %) | 1 diff (99.8 %id) | ||
BU632065 | cell lines, Chondrosarcoma | .a | 660 to 1355 | 714 to 19 | AAA | 696/696 (100 %) | 1 diff (99.9 %id) | ||
CA425934 | cell lines, Chondrosarcoma | .a | 708 to 1351 | 662 to 19 | AAA | 644/653 (98 %) | 0 diff (100 %id) | ||
BU633237 | cell lines, Chondrosarcoma | .a | 775 to 1355 | 599 to 19 | AAA | 581/581 (100 %) | 0 diff (100 %id) | ||
BX116133 | lymph node, lymphoma, follicular mixed small and largecell | .a | 245 to 1051 | 21 to 832 | This clone was ignored | 812/927 (87 %) | 22 diff (97.7 %id) | ||
BX356095 | Placenta Cot 25-normalized | .a | 245 to 1051 | 21 to 832 | This clone was ignored | 812/927 (87 %) | 22 diff (97.7 %id) | ||
BX356096 | Placenta Cot 25-normalized | .a | 566 to 1349 | 794 to 6 | This clone was ignored | 789/918 (85 %) | 12 diff (98.7 %id) | ||
AA989519 | 2 pooled tumors (clear cell type), Kidney | .a | 566 to 1349 | 794 to 6 | This clone was ignored | 789/918 (85 %) | 12 diff (98.7 %id) | ||
BE410807 | choriocarcinoma, placenta | .b | 212 to 733 | 1 to 526 | available from MGC, | This clone was ignored | 526/771 (68 %) | 13 diff (98.4 %id) | |
BM804995 | ovary (pool of 3) | .b | 212 to 733 | 1 to 526 | This clone was ignored | 526/771 (68 %) | 13 diff (98.4 %id) | ||
CA487554 | .b | 215 to 716 | 1 to 503 | 503/1073 (46 %) | 29 diff (97.3 %id) | ||||
CA454574 | .a | 224 to 916 | 1 to 693 | 693/854 (81 %) | 17 diff (98.1 %id) | ||||
CA454722 | .b | 197 to 589 | 1 to 393 | 393/982 (40 %) | 5 diff (99.5 %id) | ||||
CA454881 | .a | 270 to 994 | 1 to 728 | 728/937 (77 %) | 12 diff (98.8 %id) | ||||
CB960578 | Human Placenta, placenta | .a | 197 to 948 | 19 to 770 | 752/771 (97 %) | 8 diff (99.0 %id) | |||
CB960578 | Human Placenta, placenta | .a | 197 to 948 | 19 to 770 | 752/771 (97 %) | 8 diff (99.0 %id) | |||
CB959592 | Human Placenta, placenta | .a | 626 to 1249 | 27 to 654 | 628/822 (76 %) | 18 diff (97.9 %id) | |||
CB959592 | Human Placenta, placenta | .a | 626 to 1249 | 27 to 654 | 628/822 (76 %) | 18 diff (97.9 %id) | |||
CD518858 | White Matter | .a | 187 to 969 | 1 to 785 | 785/873 (89 %) | 9 diff (99.0 %id) | |||
TI_57217081 | .a | 713 to 1279 | 35 to 600 | 566/600 (94 %) | 6 diff (99.0 %id) | ||||
TI_57196473 | .a | 214 to 1055 | 34 to 880 | 847/880 (96 %) | 14 diff (98.5 %id) | ||||
TI_57183967 | .a | 255 to 1132 | 61 to 946 | 886/949 (93 %) | 54 diff (94.4 %id) | ||||
TI_57236161 | .a | 205 to 880 | 29 to 709 | 681/709 (96 %) | 19 diff (97.4 %id) | ||||
TI_57240127 | .a | 193 to 996 | 30 to 833 | 804/833 (96 %) | 6 diff (99.3 %id) | ||||
TI_45215331 | .a | 187 to 888 | 131 to 832 | 702/832 (84 %) | 8 diff (99.1 %id) | ||||
DC362461 | Kidney | .b | 1 to 579 | 1 to 578 | 578/578 (100 %) | 1 diff (99.9 %id) | |||
CB120711 | Liver | .b | 197 to 717 | 1 to 521 | 521/521 (100 %) | 2 diff (99.7 %id) | |||
CB145111 | Liver | .d | 35 to 268 | 1 to 234 | 234/234 (100 %) | 3 diff (98.8 %id) | |||
NM_207340.1 | .a | 35 to 1353 | 1 to 1319 | exact | RefSeq, | 1319/1319 (100 %) | 2 diff (99.9 %id) | ||
DA704564 | .a | 52 to 542 | 2 to 491 | capped | 490/490 (100 %) | 1 diff (99.8 %id) | |||
DB323912 | .a | 1397 to 1934 | 539 to 1 | 539/539 (100 %) | 2 diff (99.7 %id) | ||||
CR990053 | T-Lymphocytes | .d | 8 to 602 | 1 to 595 | 595/598 (99 %) | 1 diff (99.9 %id) | |||
BM831506 | stomach | .b | 200 to 719 | 1 to 520 | 520/520 (100 %) | 1 diff (99.9 %id) | |||
BM791179 | stomach | .b | 200 to 794 | 1 to 595 | 595/595 (100 %) | 1 diff (99.9 %id) | |||
BM791695 | stomach | .b | 205 to 754 | 1 to 550 | 550/550 (100 %) | 0 diff (100 %id) | |||
BM795394 | stomach | .b | 200 to 407 | 1 to 209 | 209/209 (100 %) | 2 diff (99.1 %id) | |||
BM854545 | stomach | .b | 200 to 584 | 1 to 385 | 385/385 (100 %) | 1 diff (99.8 %id) | |||
BM797238 | Ascites, stomach | .a | 1083 to 1516 | 1 to 434 | 434/434 (100 %) | 4 diff (99.1 %id) | |||
BM797238 | Ascites, stomach | .a | 1083 to 1516 | 1 to 434 | 434/434 (100 %) | 4 diff (99.1 %id) | |||
TI_1948208667 | .a | 231 to 668 | 132 to 572 | fully sequenced, | 441/572 (77 %) | 6 diff (99.0 %id) | |||
TI_1948208668 | .a | 638 to 1085 | 581 to 124 | fully sequenced, | 458/581 (78 %) | 8 diff (98.7 %id) | |||
TI_1948209005 | .a | 231 to 791 | 124 to 684 | fully sequenced, | 561/684 (82 %) | 7 diff (99.0 %id) | |||
TI_1948209006 | .a | 760 to 1085 | 452 to 126 | fully sequenced, | 327/452 (72 %) | 1 diff (99.8 %id) | |||
DR007011 | Spleen | .d | 18 to 685 | 8 to 675 | 668/675 (98 %) | 7 diff (99.0 %id) | |||
DC395291 | testis | .b | 5 to 554 | 1 to 550 | 550/551 (99 %) | 2 diff (99.7 %id) | |||
DB094607 | testis | .b | 226 to 786 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
DC405233 | thymus | .b | 4 to 581 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
DC406006 | thymus | .b | 1 to 566 | 1 to 566 | tiling clone, | 566/566 (100 %) | 0 diff (100 %id) | ||
TI_154034516 | .d | 997 to 1625 | 697 to 82 | AAA | 616/771 (79 %) | 19 diff (97.6 %id) | |||
BM664925 | eye, optic nerve | .a | 1063 to 1355 | 311 to 19 | fully sequenced, AAA | 293/293 (100 %) | 0 diff (100 %id) | ||
BM664925 | eye, optic nerve | .a | 1063 to 1355 | 311 to 19 | fully sequenced, AAA | 293/293 (100 %) | 0 diff (100 %id) | ||
BM702244 | eye, optic nerve | .a | 891 to 1355 | 1 to 465 | fully sequenced, AAA | 465/465 (100 %) | 0 diff (100 %id) | ||
BM702244 | eye, optic nerve | .a | 891 to 1355 | 1 to 465 | fully sequenced, AAA | 465/465 (100 %) | 0 diff (100 %id) | ||
CA443600 | lung, Metastatic Chondrosarcoma | .d | 1175 to 1625 | 469 to 19 | AAA | 451/451 (100 %) | 1 diff (99.8 %id) | ||
CA443600 | lung, Metastatic Chondrosarcoma | .d | 1175 to 1625 | 469 to 19 | AAA | 451/451 (100 %) | 1 diff (99.8 %id) | ||
BU632065 | cell lines, Chondrosarcoma | .a | 660 to 1355 | 714 to 19 | AAA | 696/696 (100 %) | 1 diff (99.9 %id) | ||
BU632065 | cell lines, Chondrosarcoma | .a | 660 to 1355 | 714 to 19 | AAA | 696/696 (100 %) | 1 diff (99.9 %id) | ||
CA425934 | cell lines, Chondrosarcoma | .a | 708 to 1351 | 662 to 19 | AAA | 644/653 (98 %) | 0 diff (100 %id) | ||
CA425934 | cell lines, Chondrosarcoma | .a | 708 to 1351 | 662 to 19 | AAA | 644/653 (98 %) | 0 diff (100 %id) | ||
BU633237 | cell lines, Chondrosarcoma | .a | 775 to 1355 | 599 to 19 | AAA | 581/581 (100 %) | 0 diff (100 %id) | ||
BU633237 | cell lines, Chondrosarcoma | .a | 775 to 1355 | 599 to 19 | AAA | 581/581 (100 %) | 0 diff (100 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes C |